# A Study of AC-101 Tablets in Patients With Ulcerative Colitis

> **NCT07755241** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Accro Bioscience (Suzhou) Limited** · enrollment: 153 (estimated)

## Conditions studied

- Ulcerative Colitis (UC)

## Interventions

- **DRUG:** AC-101
- **DRUG:** AC-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07755241
- **Lead sponsor:** Accro Bioscience (Suzhou) Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-28
- **Primary completion:** 2027-11-30
- **Final completion:** 2028-02-28
- **Target enrollment:** 153 (ESTIMATED)
- **Last updated:** 2026-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07755241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07755241, "A Study of AC-101 Tablets in Patients With Ulcerative Colitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07755241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*